Sekisui Chemical to acquire Veredus Laboratories

Sekisui Chemical, a Japanese diagnostics company, is acquiring Veredus Laboratories, a Singapore-based molecular diagnostics kit maker. The deal size was not disclosed, but market sources estimate Veredus could be worth around US$83 million.

“Sekisui Chemical, a diagnostics company based in Japan, is acquiring home-grown Veredus Laboratories, a molecular diagnostics kit maker, in one of the largest exits in the local medtech space.”straitstimes.com

• 1 source
• straitstimes.comTemasek-backed Accuron Medtech divests Veredus Labs to Japan's Sekisui Medical | The Straits TimesApr 3, 2018

Summarized from public sources; check the original articles before acting on it.